Scarica l'app Stockscreener
20.09
4.15%
0.80
Pre-mercato:
20.08
-0.01
-0.05%
Omada Health Inc Borsa (OMDA) Ultime notizie
U.S. Digital Therapeutics Market Positioned for Accelerated - openPR.com
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Omada grows revenue, membership in public earnings debut - Healthcare Dive
Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest
Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria
Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India
Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa
Omada Health price target raised to $28 from $27 at Canaccord - TipRanks
Omada Health price target raised to $24 from $21 at Barclays - TipRanks
Omada Health Reports Strong Q2 2025 Growth - TipRanks
Omada Health reports Q2 EPS (24c), consensus (13c) - TipRanks
Omada Health beats on revenue in first earnings report since IPO - CNBC
Omada Health Reports Second Quarter 2025 Results - The Manila Times
Earnings Flash (OMDA) Omada Health, Inc. Reports Q2 Revenue $61.4M, vs. FactSet Est of $55.3M - MarketScreener
U.S. Digital Therapeutics Market to Witness Remarkable Growth - openPR.com
Omada Health, Inc. (NASDAQ:OMDA) Receives $23.86 Average PT from Analysts - Defense World
Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook - TipRanks
Health Coach Market is evolving rapidly Through 2025 To 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Digital Therapeutics for Diabetes Market is projected to reach - openPR.com
Omada Health: A Buy Rating for a Company with Strong Distribution Partnerships and Clinical Validation - AInvest
Omada Health: Long Growth Runway Ahead - Seeking Alpha
Omada Health Sets Q2 Earnings Date: Virtual Healthcare Leader Reports August 7 - Stock Titan
Interleukin Inhibitors Market Generated Opportunities, Future Scope by 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Omada Health, Inc.: A Promising Buy Amid Technical Weakness and Growth Potential - TipRanks
IPO market remains 'sluggish' despite recent San Francisco listings - The Business Journals
EQBK issues 1.73M shares, completes NBC merger & adds new director | OMDA SEC FilingForm 4 - Stock Titan
More than $16B in med-tech funding raised through 1H25 - BioWorld MedTech
The Making of Omada Health | Omada Health Co-Founder & CEO Sean Duffy - iHeart
These are the 9 healthcare startups next in line to go public, according to bankers and investors - Business Insider
Omada Health IPO signals healthier market, avoids ‘down-round’ trend - MSN
Health Coach Market Set to Witness Significant Growth by 2025-2032 | Noom, Inc., HealthifyMe, Omada Health - newstrail.com
Omada Health Stock (OMDA): A Growth Story in Digital Health - Value The Markets
Omada Health stock initiated with Buy rating at Freedom Broker - Investing.com
Needham initiates coverage on Omada Health stock with Buy rating By Investing.com - Investing.com India
Omada Health initiated with a Buy at Needham - TipRanks
Omada Health initiated with an Overweight at JPMorgan - TipRanks
Omada Health initiated with an Overweight at Morgan Stanley - TipRanks
Omada Health initiated with an Overweight at Barclays - TipRanks
Don’t expect a wave of digital health IPOs quite yet - Modern Healthcare
Omada Health initiated with a Buy at Goldman Sachs - TipRanks
Omada Health: A Compelling Investment Opportunity in Digital Health with Strong Growth Potential - TipRanks
Omada Health: Strong Growth Prospects and Path to Profitability with Undervalued Potential - TipRanks
The long-awaited digital health IPO is back, but most late-stage healthcare startups aren't ready for it, according to bankers - Business Insider
Here are 12 Bay Area companies to watch for IPOs after Chime - The Business Journals
Omada Health prices IPO at $19 a share, raises $150M - MSN
Caris settles IPO at $21, trading starts at $28 - BioWorld MedTech
Health Coach Market Is Booming So Rapidly 2025-2032 -Noom, Inc., HealthifyMe, Omada Health, Inc., Iora Health - openPR.com
Omada Health releases new data on its GLP-1 companion program - Yahoo Finance
New Data: Omada Health GLP-1 Program Doubles Weight Loss Success vs Standard Care - Stock Titan
Digital Therapeutics Market: Opportunities in Mental Health - openPR.com
Omada Health (NASDAQ:OMDA) Upgraded to Hold at Wall Street Zen - Defense World
Digital Musculoskeletal (MSK) Care Market Is Booming So Rapidly - openPR.com
Should You Buy Omada Health Stock After the OMDA IPO? - MSN
11.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):